SKF-96365 activates cytoprotective autophagy to delay apoptosis in colorectal cancer cells through inhibition of the calcium/CaMKIIγ/AKT-mediated pathway.

[1]  S. Selvaraj,et al.  Resveratrol activates autophagic cell death in prostate cancer cells via downregulation of STIM1 and the mTOR pathway , 2016, Molecular carcinogenesis.

[2]  Feng Wang,et al.  Piperlongumine induces apoptosis and autophagy in human lung cancer cells through inhibition of PI3K/Akt/mTOR pathway , 2015, International journal of immunopathology and pharmacology.

[3]  Yiming Yang,et al.  Ca2+/calmodulin-dependent protein kinase IIγ enhances stem-like traits and tumorigenicity of lung cancer cells , 2015, Oncotarget.

[4]  Shufeng Zhou,et al.  The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells , 2015, Drug design, development and therapy.

[5]  R. Duncan,et al.  Sodium-Calcium Exchanger 1 Regulates Epithelial Cell Migration via Calcium-dependent Extracellular Signal-regulated Kinase Signaling* , 2015, The Journal of Biological Chemistry.

[6]  Shao-kai Wang,et al.  Asparaginase induces apoptosis and cytoprotective autophagy in chronic myeloid leukemia cells , 2015, Oncotarget.

[7]  Shun-Tai Yang,et al.  Fluoxetine, an antidepressant, suppresses glioblastoma by evoking AMPAR-mediated calcium-dependent apoptosis , 2014, Oncotarget.

[8]  Q. Wu,et al.  STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer , 2014, Oncogene.

[9]  Dali Zhao,et al.  Down-regulation of AKT combined with radiation-induced autophagy and apoptosis roles in MCF-7 cells. , 2015, Bio-medical materials and engineering.

[10]  Ying Wu,et al.  Effects of calcium signaling on coagulation factor VIIa-induced proliferation and migration of the SW620 colon cancer cell line. , 2014, Molecular medicine reports.

[11]  Xiaodong Wang,et al.  Activation of mitochondrial protease OMA1 by Bax and Bak promotes cytochrome c release during apoptosis , 2014, Proceedings of the National Academy of Sciences.

[12]  M. Hou,et al.  STIM1 Overexpression Promotes Colorectal Cancer Progression, Cell Motility and COX-2 Expression , 2014, Oncogene.

[13]  K. Burnstein,et al.  A novel calcium-dependent mechanism of acquired resistance to IGF-1 receptor inhibition in prostate cancer cells , 2014, Oncotarget.

[14]  C. Stournaras,et al.  Enhanced Orai1 and STIM1 expression as well as store operated Ca2+ entry in therapy resistant ovary carcinoma cells , 2014, Oncotarget.

[15]  Liwu Fu,et al.  Elevated Orai1 expression mediates tumor-promoting intracellular Ca2+ oscillations in human esophageal squamous cell carcinoma , 2014, Oncotarget.

[16]  A. Siddiqui,et al.  Hepatitis C virus triggers mitochondrial fission and attenuates apoptosis to promote viral persistence , 2014, Proceedings of the National Academy of Sciences.

[17]  Hongming Pan,et al.  p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents. , 2014, Cancer letters.

[18]  Min Zhang,et al.  RETRACTED: Ca(2+)/calmodulin-dependent protein kinase IIγ, a critical mediator of the NF-κB network, is a novel therapeutic target in non-small cell lung cancer. , 2014, Cancer letters.

[19]  P. Dent,et al.  The role of cell signalling in the crosstalk between autophagy and apoptosis. , 2014, Cellular signalling.

[20]  C. Romanin,et al.  STIM1/Orai1 coiled-coil interplay in the regulation of store-operated calcium entry , 2013, Nature Communications.

[21]  Z. Huang,et al.  Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment , 2013, Cell Death and Disease.

[22]  Y. Yen,et al.  Berbamine Inhibits the Growth of Liver Cancer Cells and Cancer-Initiating Cells by Targeting Ca2+/Calmodulin-Dependent Protein Kinase II , 2013, Molecular Cancer Therapeutics.

[23]  Y. Yen,et al.  Berbamine Inhibits the Growth of Liver Cancer Cells and Cancer-Initiating Cells by Targeting Ca 2þ /Calmodulin- , 2013 .

[24]  Z. Meng,et al.  CaMKII γ, a critical regulator of CML stem/progenitor cells, is a target of the natural product berbamine. , 2012, Blood.

[25]  M. Zou,et al.  Store-operated Ca2+ Entry (SOCE) Plays a Role in the Polarization of Neutrophil-like HL-60 Cells by Regulating the Activation of Akt, Src, and Rho Family GTPases , 2012, Cellular Physiology and Biochemistry.

[26]  D. Fishman,et al.  Lipid rafts couple store-operated Ca2+ entry to constitutive activation of PKB/Akt in a Ca2+/calmodulin-, Src- and PP2A-mediated pathway and promote melanoma tumor growth. , 2012, Carcinogenesis.

[27]  A. Ogawa,et al.  PDGF enhances store-operated Ca2+ entry by upregulating STIM1/Orai1 via activation of Akt/mTOR in human pulmonary arterial smooth muscle cells. , 2012, American journal of physiology. Cell physiology.

[28]  S. Moro,et al.  MG-2477, a new tubulin inhibitor, induces autophagy through inhibition of the Akt/mTOR pathway and delayed apoptosis in A549 cells. , 2012, Biochemical pharmacology.

[29]  Y. Zhan,et al.  Role of store-operated calcium entry in imperatorin-induced vasodilatation of rat small mesenteric artery. , 2010, European journal of pharmacology.

[30]  S. Rikka,et al.  Bnip3 mediates permeabilization of mitochondria and release of cytochrome c via a novel mechanism. , 2010, Journal of molecular and cellular cardiology.

[31]  I. Sekler,et al.  Coupling of mitochondria to store-operated Ca(2+)-signaling sustains constitutive activation of protein kinase B/Akt and augments survival of malignant melanoma cells. , 2010, Cell calcium.

[32]  Kechun Zhou,et al.  Blockade of TRPC6 channels induced G2/M phase arrest and suppressed growth in human gastric cancer cells , 2009, International journal of cancer.

[33]  M. Ikura,et al.  Structural and Mechanistic Insights into STIM1-Mediated Initiation of Store-Operated Calcium Entry , 2008, Cell.

[34]  S. Collins,et al.  Activated Ca2+/calmodulin-dependent protein kinase IIgamma is a critical regulator of myeloid leukemia cell proliferation. , 2008, Cancer research.

[35]  E. Perez,et al.  Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51). , 2008, Lung cancer.

[36]  H. D. Guthrie,et al.  Determination of high mitochondrial membrane potential in spermatozoa loaded with the mitochondrial probe 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolyl-carbocyanine iodide (JC-1) by using fluorescence-activated flow cytometry. , 2008, Methods in molecular biology.

[37]  J. Armstrong,et al.  Bax and the mitochondrial permeability transition cooperate in the release of cytochrome c during endoplasmic reticulum-stress-induced apoptosis , 2007, Cell Death and Differentiation.

[38]  B. Herman,et al.  Discrimination of depolarized from polarized mitochondria by confocal fluorescence resonance energy transfer. , 2004, Archives of biochemistry and biophysics.

[39]  Sherry F. Grissom,et al.  The mitochondrial permeability transition initiates autophagy in rat hepatocytes , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  Y. Leung,et al.  Current perspectives in the pharmacological studies of store-operated Ca2+ entry blockers. , 1999, Japanese journal of pharmacology.

[41]  D. Schomburg,et al.  Ca 2+ /calmodulin-dependent protein kinase , 1997 .

[42]  E. Kohn,et al.  Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers. , 1996, Cancer research.

[43]  W. Jonat,et al.  Randomized phase II study of single-agent epirubicin +/− verapamil in patients with advanced metastatic breast cancer , 1993 .

[44]  W. Jonat,et al.  Randomized phase II study of single-agent epirubicin +/— verapamil in patients with advanced metastatic breast cancer: An AIO clinical trial , 1993 .

[45]  W. Jonat,et al.  Randomized phase II study of single-agent epirubicin +/- verapamil in patients with advanced metastatic breast cancer. An AIO clinical trial. Arbeitsgemeinschaft Internistische Onkologie of the German Cancer Society. , 1993, Annals of oncology : official journal of the European Society for Medical Oncology.